Immatics (IMTXW) Competitors

Immatics logo
$0.04 -0.03 (-46.22%)
As of 02/14/2025 04:00 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

IMTXW vs. ATNFW, LBPSW, AEHAW, AIMDW, ALVOW, ACABW, BFRIW, BTMDW, BCTXW, and CELUW

Should you be buying Immatics stock or one of its competitors? The main competitors of Immatics include 180 Life Sciences (ATNFW), 4D pharma (LBPSW), Aesther Healthcare Acquisition (AEHAW), Ainos (AIMDW), Alvotech (ALVOW), Atlantic Coastal Acquisition Corp. II (ACABW), Biofrontera (BFRIW), biote (BTMDW), BriaCell Therapeutics (BCTXW), and Celularity (CELUW). These companies are all part of the "pharmaceutical products" industry.

Immatics vs.

Immatics (NASDAQ:IMTXW) and 180 Life Sciences (NASDAQ:ATNFW) are both medical companies, but which is the better investment? We will compare the two businesses based on the strength of their community ranking, media sentiment, earnings, profitability, risk, analyst recommendations, dividends, valuation and institutional ownership.

Company Net Margins Return on Equity Return on Assets
ImmaticsN/A N/A N/A
180 Life Sciences N/A N/A N/A

Immatics and 180 Life Sciences both received 0 outperform votes by MarketBeat users.

CompanyUnderperformOutperform
ImmaticsN/AN/A
180 Life SciencesN/AN/A

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Immatics$115.50MN/AN/AN/AN/A
180 Life SciencesN/AN/AN/AN/AN/A

In the previous week, 180 Life Sciences' average media sentiment score of 1.40 beat Immatics' score of 0.00 indicating that 180 Life Sciences is being referred to more favorably in the news media.

Company Overall Sentiment
Immatics Neutral
180 Life Sciences Positive

Summary

Immatics and 180 Life Sciences tied by winning 1 of the 2 factors compared between the two stocks.

Get Immatics News Delivered to You Automatically

Sign up to receive the latest news and ratings for IMTXW and its competitors with MarketBeat's FREE daily newsletter.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

IMTXW vs. The Competition

MetricImmaticsBiotechnology IndustryMedical SectorNASDAQ Exchange
Market CapN/A$113.83M$5.88B$9.20B
Dividend YieldN/A3.78%5.29%4.00%
P/E RatioN/A3.2415.6114.06
Price / SalesN/A5,147.54475.1478.34
Price / CashN/A12.7546.1738.90
Price / BookN/A48.717.285.05
Net IncomeN/A-$91.48M$3.19B$222.67M
7 Day PerformanceN/A-1.41%2.84%2.11%
1 Month PerformanceN/A4.90%4.66%2.36%
1 Year PerformanceN/A103.44%22.88%16.83%

Immatics Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
IMTXW
Immatics
N/A$0.05
-33.3%
N/A-98.6%$0.00$115.50M0.00260Gap Up
ATNFW
180 Life Sciences
N/A$0.01
+10.8%
N/A+31.0%$0.00N/A0.007Gap Up
LBPSW
4D pharma
N/AN/AN/AN/A$0.00$522,000.000.00N/A
AEHAW
Aesther Healthcare Acquisition
N/A$0.03
+7.6%
N/A-14.6%$0.00N/A0.002Gap Down
AIMDW
Ainos
N/A$0.15
flat
N/A+159.0%$0.00$40,633.000.0040
ALVOW
Alvotech
N/A$2.20
-8.3%
N/A-38.8%$0.00$391.87M0.004Gap Down
ACABW
Atlantic Coastal Acquisition Corp. II
N/A$0.05
flat
N/A-33.1%$0.00N/A0.004
BFRIW
Biofrontera
N/A$0.06
-6.3%
N/A+454.9%$0.00$35.36M0.0070High Trading Volume
BTMDW
biote
N/A$0.50
flat
N/A-50.0%$0.00$193.06M0.00N/A
BCTXW
BriaCell Therapeutics
N/A$0.12
+0.2%
N/A-91.0%$0.00N/A0.008Short Interest ↓
News Coverage
Gap Down
CELUW
Celularity
N/A$0.07
flat
N/A+72.4%$0.00$48.20M0.00220Gap Up

Related Companies and Tools


This page (NASDAQ:IMTXW) was last updated on 2/15/2025 by MarketBeat.com Staff
From Our Partners